Literature DB >> 33730227

Outcomes of Esophageal Stent Therapy for the Management of Anastomotic Leaks.

Toni S Carter1, Prejesh Philips1, Michael Egger1, Charles Scoggins1, Robert C G Martin2.   

Abstract

BACKGROUND: The purpose of this study was to present the optimal patient selection for esophageal stenting after esophageal resection to investigate possible factors leading to treatment success or treatment failure in these patients.
METHODS: This was a prospective, observational study of patients from January 2005 to May 2019 with an esophageal anastomotic leak that were treated with a self-expandable stent (SES).
RESULTS: A total of 34 patients were treated. All achieved technical success (100%); 33 (97%) achieved clinical success. No patient had to have reoperative surgery based on their leak management. The stenting in-hospital mortality was 0% with 1 patient (2%) with a 90-day mortality from possible leak-related death. Patients had their stents removed with a median of 106 days.
CONCLUSIONS: Stenting for an anastomotic leak after resection offers a safe and effective method of treatment and is successful in the majority of cases. Critical to success is optimal patient selection, adequate leak drainage, and optimal stent selection and placement.
© 2021. Society of Surgical Oncology.

Entities:  

Year:  2021        PMID: 33730227     DOI: 10.1245/s10434-021-09669-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  2 in total

Review 1.  Recent Updates in Gastrointestinal Stent Placement from the Esophagus to the Colon: A Radiological Perspective.

Authors:  Gun Ha Kim; Ji Hoon Shin; Chu Hui Zeng; Jung Hoon Park
Journal:  Cardiovasc Intervent Radiol       Date:  2022-02-15       Impact factor: 2.740

2.  The Association between Neoadjuvant Radio-Chemotherapy and Prolonged Healing of Anastomotic Leakage after Esophageal Resection Treated with EndoVAC Therapy.

Authors:  Philippa Seika; Matthias Biebl; Jonas Raakow; Nadja Berndt; Linda Feldbrügge; Max Magnus Maurer; Eva Dobrindt; Peter Thuss-Patience; Johann Pratschke; Christian Denecke
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.